HTSUF
Price
$28.94
Change
-$3.36 (-10.40%)
Updated
Jun 10 closing price
Capitalization
2.06B
HYPMY
Price
$4.22
Change
+$0.18 (+4.46%)
Updated
Aug 15 closing price
Capitalization
2.7B
Interact to see
Advertisement

HTSUF vs HYPMY

Header iconHTSUF vs HYPMY Comparison
Open Charts HTSUF vs HYPMYBanner chart's image
Hisamitsu Pharmaceutical
Price$28.94
Change-$3.36 (-10.40%)
Volume$100
Capitalization2.06B
Hypera SA
Price$4.22
Change+$0.18 (+4.46%)
Volume$742
Capitalization2.7B
HTSUF vs HYPMY Comparison Chart in %
Loading...
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HTSUF vs. HYPMY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUF is a Hold and HYPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (HTSUF: $28.94 vs. HYPMY: $4.22)
Brand notoriety: HTSUF and HYPMY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HTSUF: 100% vs. HYPMY: 0%
Market capitalization -- HTSUF: $2.06B vs. HYPMY: $2.7B
HTSUF [@Pharmaceuticals: Generic] is valued at $2.06B. HYPMY’s [@Pharmaceuticals: Generic] market capitalization is $2.7B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUF’s FA Score shows that 0 FA rating(s) are green whileHYPMY’s FA Score has 2 green FA rating(s).

  • HTSUF’s FA Score: 0 green, 5 red.
  • HYPMY’s FA Score: 2 green, 3 red.
According to our system of comparison, HYPMY is a better buy in the long-term than HTSUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUF’s TA Score shows that 0 TA indicator(s) are bullish while HYPMY’s TA Score has 3 bullish TA indicator(s).

  • HTSUF’s TA Score: 0 bullish, 1 bearish.
  • HYPMY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HTSUF is a better buy in the short-term than HYPMY.

Price Growth

HTSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HYPMY (@Pharmaceuticals: Generic) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($2.7B) has a higher market cap than HTSUF($2.07B). HYPMY has higher P/E ratio than HTSUF: HYPMY (19.49) vs HTSUF (15.98). HYPMY YTD gains are higher at: 43.825 vs. HTSUF (17.839). HTSUF has higher annual earnings (EBITDA): 26.4B vs. HYPMY (1.43B). HTSUF has higher revenues than HYPMY: HTSUF (150B) vs HYPMY (6.7B).
HTSUFHYPMYHTSUF / HYPMY
Capitalization2.07B2.7B77%
EBITDA26.4B1.43B1,853%
Gain YTD17.83943.82541%
P/E Ratio15.9819.4982%
Revenue150B6.7B2,240%
Total Cash123BN/A-
Total Debt1.12BN/A-
FUNDAMENTALS RATINGS
HTSUF vs HYPMY: Fundamental Ratings
HTSUF
HYPMY
OUTLOOK RATING
1..100
4378
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
8177
PRICE GROWTH RATING
1..100
5463
P/E GROWTH RATING
1..100
7612
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (8) in the null industry is significantly better than the same rating for HTSUF (92). This means that HYPMY’s stock grew significantly faster than HTSUF’s over the last 12 months.

HTSUF's Profit vs Risk Rating (68) in the null industry is in the same range as HYPMY (100). This means that HTSUF’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's SMR Rating (77) in the null industry is in the same range as HTSUF (81). This means that HYPMY’s stock grew similarly to HTSUF’s over the last 12 months.

HTSUF's Price Growth Rating (54) in the null industry is in the same range as HYPMY (63). This means that HTSUF’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's P/E Growth Rating (12) in the null industry is somewhat better than the same rating for HTSUF (76). This means that HYPMY’s stock grew somewhat faster than HTSUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HTSUFHYPMY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
12%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
15%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
66%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
26%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIVLX19.850.11
+0.56%
American Funds International Vntg R-5
FCGCX19.86N/A
N/A
Fidelity Advisor Global Commodity Stk C
JNGSX12.18N/A
N/A
Janus Henderson Global Real Estate D
TIRGX17.22N/A
N/A
T. Rowe Price Global Real Estate I
VEVRX46.48N/A
N/A
Victory Sycamore Established Value R6

HTSUF and

Correlation & Price change

A.I.dvisor tells us that HTSUF and ORGO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUF and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
ORGO - HTSUF
26%
Poorly correlated
+0.64%
PHCUF - HTSUF
26%
Poorly correlated
N/A
HYPMY - HTSUF
3%
Poorly correlated
+4.58%
IPSEY - HTSUF
3%
Poorly correlated
N/A
HLTRF - HTSUF
1%
Poorly correlated
+0.27%
More

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and PLNH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and PLNH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+4.58%
PLNH - HYPMY
21%
Poorly correlated
-8.35%
CPIX - HYPMY
20%
Poorly correlated
+4.68%
GLASF - HYPMY
20%
Poorly correlated
-6.40%
KMDA - HYPMY
20%
Poorly correlated
+0.68%
JUSHF - HYPMY
18%
Poorly correlated
-10.65%
More